TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
JNJ

Johnson & Johnson

Healthcare · Drug Manufacturers - General

270.20$ +1.1% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Johnson & Johnson (JNJ) with date, type and a link to the original document.

Filings JNJ
Date Type Filing Original
09/02/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/17/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/13/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/06/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/05/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/04/2026 Current report (8-K) JOHNSON & JOHNSON (JNJ): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits View report ↗
07/29/2026 Current report (8-K) JOHNSON & JOHNSON (JNJ): Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
07/28/2026 Current report (8-K) JOHNSON & JOHNSON (JNJ): Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
07/20/2026 Insider sale notice Form 144 filed with the SEC View document ↗
07/15/2026 Current report (8-K) JOHNSON & JOHNSON (JNJ): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?